Immunotherapy for TNBC in the Perioperative Setting: Clinical Evidence and Considerations
Peter Schmid, FRCP, MD, PhD
Innovations in Oncology Learning Center From Guidelines to Practice: Gastrointestinal Cancers
Sara Lonardi, MD
Aparna R. Parikh, MD
Alan Venook, MD
Current Guideline Recommendations for Biomarker-Based Second-Line Treatment of mCRC
Expert Viewpoint: Optimizing Breast Cancer Treatment
William J. Gradishar, MD
Erica L. Mayer, MD, MPH
First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study
Biomarker-Directed Approaches for Frontline Treatment of Advanced Gastric/GEJ Cancers: The Evidence
Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion
The Evolving Treatment Landscape for MBC: Emerging Therapies
Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases
Jacob Sands, MD
Aaron Lisberg, MD
Evaluating Valemetostat and Dato-DXd for NSCLC: An Upcoming Trial
Alex Spira, MD, PhD, FACP
Detecting Recurrent Breast Cancer: The Role of Liquid Biopsies and Molecular Markers
Ben Park, MD, PhD
Dato-DxD for NSCLC: A Review of Final Overall Survival Data from TROPION-Lung01
Treating NSCLC with Durvalumab, Chemotherapy, and Novel Agents: Preliminary Results
Charles Turck, PharmD, BCPS, BCCCP
Thomas Egenod, MD
Targeted Therapy in the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Ritu Salani, MD, MBA
Nicoletta Colombo, MD
Innovations in Oncology Learning Center From Guidelines to Practice: Genitourinary Cancers
Ignacio Duran, MD
Wenxin Xu, MD
Sandy Srinivas, MD
Implementing Guideline-Concordant Care Into a Targeted Therapy Approach for Patients With Platinum-Resistant Ovarian Cancer
Susana Campos, MD, MPH
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.